Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Judy Hope"'
Autor:
Judy Hope, Nicholas A Keks
Publikováno v:
Australasian Psychiatry. 30:382-385
Objective Cariprazine is the third partial dopamine agonist now available in Australia. This paper will review the properties, evidence and likely clinical place of cariprazine. Conclusion Cariprazine is a partial agonist with high affinity at dopami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1414f1655386c13200edef8f08f7242
https://doi.org/10.1177/10398562211064254
https://doi.org/10.1177/10398562211064254
Publikováno v:
Frontiers in Health Services. 1
Objective: To identify processes to engage stakeholders in healthcare Simulation Modeling (SM), and the impacts of this engagement on model design, model implementation, and stakeholder participants. To investigate how engagement process may lead to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d7a9f302afb76a1e218b79b72e70d0d
https://doi.org/10.3389/frhs.2021.644831
https://doi.org/10.3389/frhs.2021.644831
Autor:
Michele Orr, Phoebe Williamson, Rebecca Garbutt, Judy Hope, Lisa Gill, Brooke Trevorah, Pieter Hurter, Jose Segal
Publikováno v:
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 29(3)
Objective: To review the Hospital Outreach Post-suicidal Engagement (HOPE) service in the first six months of the pilot program in a metropolitan Melbourne setting, including a description of: (a) socio-demographic, health and psychosocial stressors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d960458c635e778213452885e10cae9
https://pubmed.ncbi.nlm.nih.gov/33356417
https://pubmed.ncbi.nlm.nih.gov/33356417
Publikováno v:
Australasian Psychiatry. 27:25-31
Objectives: To perform a clinical and risk audit of private hospital inpatients staying in hospital at least 21 days. Methods: Of 492 admissions for ≥21 days in 2016, 40 were randomly selected for audit. Characteristics, illness severity and course
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d42711d16267b5b24b7f4db635930e2
https://doi.org/10.1177/1039856218804345
https://doi.org/10.1177/1039856218804345
Publikováno v:
Australasian Psychiatry. 26:537-540
Objective: Milnacipran is a serotonin noradrenaline reuptake inhibitor (SNRI) approved for treatment of fibromyalgia in Australia, but is used for depression in Europe and elsewhere. This paper will briefly review milnacipran and its utility in psych
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97afbae40f34da80226a996c9007e91c
https://doi.org/10.1177/1039856218794874
https://doi.org/10.1177/1039856218794874
Publikováno v:
Australasian Psychiatry. 26:92-94
Objectives: Brexpiprazole is a new dopamine partial agonist antipsychotic in the same class as aripiprazole. This paper will briefly review brexpiprazole and compare it with aripiprazole. Conclusions: Brexpiprazole and aripiprazole are both partial a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61302abd6ff975ef64d30638b3a5c76a
https://doi.org/10.1177/1039856217732473
https://doi.org/10.1177/1039856217732473
Publikováno v:
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 25(6)
Objective: Suvorexant, a new hypnotic, is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance, and is used long-term. This paper will briefly review suvorexant. Results: Orexin is a hypothal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e4c968a7a0106fd921c35a42ad676ad
https://pubmed.ncbi.nlm.nih.gov/28994603
https://pubmed.ncbi.nlm.nih.gov/28994603
Publikováno v:
Australian Prescriber
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff43aea5fa4a9e64e385dc3e30958a44
http://europepmc.org/articles/PMC6787302
http://europepmc.org/articles/PMC6787302
Publikováno v:
Australian Prescriber
In general, specialist advice should be sought when stopping or switching antipsychotics While antipsychotics are often needed long term, there are circumstances when clinicians, patients and families should reconsider the benefits versus the harms o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6706c15e7b12a35a84fb6de4362c3263
https://doi.org/10.18773/austprescr.2019.052
https://doi.org/10.18773/austprescr.2019.052
Switching from one antidepressant to another is frequently indicated due to an inadequate treatment response or unacceptable adverse effects. All antidepressant switches must be carried out cautiously and under close observation. Conservative switchi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a81687a9badbffcbdee93a2804bdc42
https://europepmc.org/articles/PMC4919171/
https://europepmc.org/articles/PMC4919171/
